Growing community of inventors

Paris, France

Giuseppe Ronzitti

Average Co-Inventor Count = 3.26

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 8

Giuseppe RonzittiFederico Mingozzi (5 patents)Giuseppe RonzittiDwight D Koeberl (1 patent)Giuseppe RonzittiLaura Cancedda (1 patent)Giuseppe RonzittiPatrice Vidal (1 patent)Giuseppe RonzittiGiulia Bortolussi (1 patent)Giuseppe RonzittiAndrea Contestabile (1 patent)Giuseppe RonzittiAndrés Muro (1 patent)Giuseppe RonzittiFanny Collaud (1 patent)Giuseppe RonzittiSang-Oh Han (1 patent)Giuseppe RonzittiGiuseppe Ronzitti (5 patents)Federico MingozziFederico Mingozzi (15 patents)Dwight D KoeberlDwight D Koeberl (18 patents)Laura CanceddaLaura Cancedda (2 patents)Patrice VidalPatrice Vidal (1 patent)Giulia BortolussiGiulia Bortolussi (1 patent)Andrea ContestabileAndrea Contestabile (1 patent)Andrés MuroAndrés Muro (1 patent)Fanny CollaudFanny Collaud (1 patent)Sang-Oh HanSang-Oh Han (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Genethon (5 from 54 patents)

2. Institut National De La Sante Et De La Recherche Medicale (3 from 1,743 patents)

3. Université D'evry-val-d'essonne (3 from 21 patents)

4. Sorbonne Université (2 from 237 patents)

5. Duke University (1 from 2,009 patents)

6. Fondazione Istituto Italiano Di Tecnologia (1 from 138 patents)

7. Fondazione Telethon (1 from 35 patents)

8. International Centre for Genetic Engineering and Biotechnology (1 from 6 patents)


5 patents:

1. 11541131 - Treatment of glycogen storage disease III

2. 11427836 - Method for reducing the expression of NKCC1 in a subject

3. 11421211 - Acid-alpha glucosidase variants and uses thereof

4. 11339406 - Acid-alpha glucosidase variants and uses thereof

5. 10471132 - Treatment of hyperbilirubinemia

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/27/2025
Loading…